Shaping cardiac destiny: the role of post-translational modifications on endoplasmic reticulum – mitochondria crosstalk in cardiac remodeling DOI Creative Commons
Xiaohan Zhang,

Shuqing Shi,

Yihang Du

et al.

Frontiers in Pharmacology, Journal Year: 2024, Volume and Issue: 15

Published: Oct. 11, 2024

Cardiac remodeling is a shared pathological change in most cardiovascular diseases. Encompassing both adaptive physiological responses and decompensated changes. Anatomically, atrial primarily caused by fibrillation, whereas ventricular typically induced myocardial infarction, hypertension, or cardiomyopathy. Mitochondria, the powerhouse of cardiomyocytes, collaborate with other organelles such as endoplasmic reticulum to control variety pathophysiological processes calcium signaling, lipid transfer, mitochondrial dynamics, biogenesis, mitophagy. This mechanism proven be essential for cardiac remodeling. Post-translational modifications can regulate intracellular signaling pathways, gene expression, cellular stress cells modulating protein function, stability, interactions, consequently shaping response injury stress. These modifications, particular phosphorylation, acetylation, ubiquitination, are regulation complex molecular pathways that underlie review provides comprehensive overview crosstalk between mitochondria during remodeling, focusing on regulatory effects various post-translational these interactions.

Language: Английский

New Mechanisms to Prevent Heart Failure with Preserved Ejection Fraction Using Glucagon-like Peptide-1 Receptor Agonism (GLP-1 RA) in Metabolic Syndrome and in Type 2 Diabetes: A Review DOI Open Access
Jorge Jalil, Luigi Gabrielli, María Paz Ocaranza

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(8), P. 4407 - 4407

Published: April 17, 2024

This review examines the impact of obesity on pathophysiology heart failure with preserved ejection fraction (HFpEF) and focuses novel mechanisms for HFpEF prevention using a glucagon-like peptide-1 receptor agonism (GLP-1 RA). Obesity can lead to through various mechanisms, including low-grade systemic inflammation, adipocyte dysfunction, accumulation visceral adipose tissue, increased pericardial/epicardial tissue (contributing an increase in myocardial fat content interstitial fibrosis). Glucagon-like peptide 1 (GLP-1) is incretin hormone that released from enteroendocrine L-cells gut. GLP-1 reduces blood glucose levels by stimulating insulin synthesis, suppressing islet α-cell function, promoting proliferation differentiation β-cells. regulates gastric emptying appetite, RA currently indicated treating type 2 diabetes (T2D), obesity, metabolic syndrome (MS). Recent evidence indicates may play significant role preventing patients MS, or obese T2D. effect be due activating cardioprotective (the endogenous counter-regulatory renin angiotensin system AMPK/mTOR pathway) inhibiting deleterious remodeling PKA/RhoA/ROCK pathway, aldosterone levels, microinflammation). However, there still need further research validate these humans.

Language: Английский

Citations

8

Identification of Circulating Plasma Proteins as a Mediator of Hypertension-Driven Cardiac Remodeling: A Mediation Mendelian Randomization Study DOI Creative Commons
Yuanlong Hu, Lin Lin, Lei Zhang

et al.

Hypertension, Journal Year: 2024, Volume and Issue: 81(5), P. 1132 - 1144

Published: March 15, 2024

This study focused on circulating plasma protein profiles to identify mediators of hypertension-driven myocardial remodeling and heart failure.

Language: Английский

Citations

7

Myocardial fibrosis from the perspective of the extracellular matrix: mechanisms to clinical impact DOI
Ida G. Lunde, Karoline Bjarnesdatter Rypdal, Sophie Van Linthout

et al.

Matrix Biology, Journal Year: 2024, Volume and Issue: 134, P. 1 - 22

Published: Aug. 29, 2024

Language: Английский

Citations

7

Dan-shen Yin attenuates myocardial fibrosis after myocardial infarction in rats: molecular mechanism insights by integrated transcriptomics and network pharmacology analysis and experimental validation DOI
Xuan Gao,

Chenyang Ni,

Yingying Song

et al.

Journal of Ethnopharmacology, Journal Year: 2024, Volume and Issue: 338, P. 119070 - 119070

Published: Nov. 8, 2024

Language: Английский

Citations

4

ROS-responsive core–shell microgels for phase-specific treatment of myocardial infarction via programmed drug delivery DOI
Liang Song,

Weiwei Zheng,

Shuqin Wang

et al.

Chemical Engineering Journal, Journal Year: 2025, Volume and Issue: unknown, P. 160295 - 160295

Published: Feb. 1, 2025

Language: Английский

Citations

0

Deep Learning-Enhanced Light Sheet Microscopy Unveils Semaglutide Impact on Cardiac Fibrosis DOI Creative Commons

Sheyla Barrado-Ballestero,

Sarah Torp Yttergren,

Max Hahn

et al.

bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2025, Volume and Issue: unknown

Published: March 1, 2025

Abstract Background Extensive preclinical research aims to develop novel therapeutics for myocardial fibrosis (MF), a condition marked by collagen accumulation that impairs cardiac function. MF is particularly relevant in heart failure with preserved ejection fraction (HFpEF), growing clinical challenge limited treatment options. However, current methods quantifying mouse models struggle accurately capture its heterogeneous regional distribution, creating significant barrier reliably assessing the efficacy of therapeutics. Purpose To whole-heart imaging and deep learning (DL)-based quantification method validate workflow glucagon-like peptide-1 receptor (GLP-1R) agonist HFpEF model. Experimental Approach By utilizing fluorescent collagen-labelling dye, tissue clearing 3D light sheet microscopy, we developed high-throughput platform MF. We established DL framework quantify perivascular replacement fibrosis, as well hypertrophy, 17 left ventricular (LV) segments. The antifibrotic effects GLP-1R semaglutide were evaluated db/db UNx-ReninAAV model, which exhibits diabetes, kidney failure, obesity, hypertension. Key Results Whole-heart combined artificial intelligence, enables micrometer-resolution analysis distribution rodents. This approach allows detailed characterization distinct patterns. Chronic significantly reduced LV hypertrophy but had no effect on fibrosis. Conclusions Implications provides powerful tool evaluating therapeutic compounds studying cellular pathological mechanisms underlying cardiovascular diseases.

Language: Английский

Citations

0

Injectable hydrogel with miR-222-engineered extracellular vesicles ameliorates myocardial ischemic reperfusion injury via mechanotransduction DOI Creative Commons
Yong-Tao Wang,

Danni Meng,

Xiaohui Shi

et al.

Cell Reports Medicine, Journal Year: 2025, Volume and Issue: unknown, P. 101987 - 101987

Published: March 1, 2025

Cardiac ischemic reperfusion injury (IRI) significantly exacerbates cardiac dysfunction and heart failure, causing high mortality. Despite the severity of IRI, effective therapeutic strategies remain elusive. Acellular patches have shown considerable efficacy in delivering therapeutics directly to tissues. Herein, we develop injectable GelMA (GEL) hydrogels with controlled mechanical properties. Targeting miR-222-engineered extracellular vesicles (TeEVs), tailored cardiac-ischemia-targeting peptides (CTPs), are developed as TeEV therapeutics. These TeEVs encapsulated within create TeEV-loaded patches, enabling minimal invasiveness attenuate IRI. The facilitate precise targeting for efficient rescue damaged cells. Persistent delivery into infarcted region alleviates acute IRI mitigated remodeling post This is linked focal adhesion activation, cytoskeleton force enhancement, nuclear force-sensing preservation. findings may pave way approaches therapy using bioengineered patches.

Language: Английский

Citations

0

Effect of atrial fibrosis on clot burden score and physicochemical properties of thrombus in patients with ischaemic stroke occurring in non-valvular atrial fibrillation DOI Creative Commons
Juan Zhao,

Guangjun Deng,

Weijing Wang

et al.

PeerJ, Journal Year: 2025, Volume and Issue: 13, P. e19173 - e19173

Published: March 24, 2025

Background To investigate the effect of degree atrial fibrosis on clot burden score (CBS) and physicochemical properties in patients with acute ischaemic stroke (AIS) due to non-valvular fibrillation (NVAF). Methods A total 117 AIS NVAF attending Department Cardiovascular Medicine Cerebrovascular Diagnostic Treatment Centre between August 2021 May 2024 were included study. Baseline clinical data, biochemical indexes, imaging data collected, divided into 93 cases CBS (score 0–6) group 24 7–10) according CBS. signifies higher burden. The enzyme-linked immunosorbent assay was used measure concentration galactaglutinin-3 (gal-3) transforming growth factor (TGF-β1) serum patients, PTFV1 collected by 12-lead electrocardiogram, differences different groups risk factors analysed. analyse collateral circulation stroke, 31 good (grade 3–4) 86 poor 0–2) digital subtraction angiography (DSA) images. cerebral thrombus from 60 who underwent mechanical thrombectomy. content erythrocyte, fibrin/platelets leukocytes analysed Mathew’s scarlet blue staining, density measured computed tomography (CT). Results this study, proportion hypertensive chronic (CAF), B-type natriuretic peptide (BNP), neutrophil/lymphocyte ratio (NLR), D-dimer, uric acid concentration, < −0.03 mm s, gal-3, TGF-β1 as compared ( P -value 0.05). Hypertension, CAF, homocysteine, NLR, acid, TGF-β1, for development high (AF), hypertension CAF most important occurrence AF independent combined gal-3 circulation, indexes not associated pathological composition density. Conclusions Atrial increases but does significantly correlate thrombus.

Language: Английский

Citations

0

Research Status of Traditional Chinese Medicine Intervention on TGF-<i>β</i>/Smads Pathway in the Treatment of Myocardial Fibrosis DOI

灵 张

Traditional Chinese Medicine, Journal Year: 2025, Volume and Issue: 14(03), P. 1178 - 1184

Published: Jan. 1, 2025

Language: Английский

Citations

0

Study on the Treatment of Cardiac Fibrosis by Traditional Chinese Medicine Based on TGF-<i>β</i>1/Smads Signaling Pathway DOI

继红 张

Traditional Chinese Medicine, Journal Year: 2025, Volume and Issue: 14(04), P. 1223 - 1231

Published: Jan. 1, 2025

Language: Английский

Citations

0